News | December 19, 2014

Two Guidelines Added to ACC Guideline Clinical App

App provides mobile access to guidelines, tools for treatment, prevention of heart disease

Atrial fibrillation, heart valve repair, software, mobile devices, ACC app

December 19, 2014 — The American College of Cardiology’s recently released Guideline Clinical App has expanded with the addition of tools and guideline content for two conditions, valvular heart disease and atrial fibrillation.

The ACC Guideline Clinical App was launched in November with the initial version including content based on guidelines for heart failure, cardiovascular risk assessment and treatment of blood cholesterol. In addition to the Executive Summary and Top 10 Points for each guideline, the app includes a collection of interactive tools such as dosing calculators, scoring tools and algorithms useful to clinicians in determining recommended care.

The ACC, which has been developing clinical practice guidelines in partnership with the American Heart Association for more than three decades, developed this app to serve as a mobile home for all ACC/AHA guideline content and related tools.

The ACC will continue to refine and expand the app. An additional update is expected in March with content and tools based on guidelines for the treatment of obesity and the management of lifestyle to reduce cardiovascular risk.

The American College of Cardiology Guideline Clinical App is available for free on iTunes and GooglePlay.

For more information: www.acc.org

 

Related Content

Boston Scientific Prevails in U.S. Edwards Lifesciences Litigation
Feature | Heart Valve Technology | December 12, 2018
A jury in the U.S. District Court for the District of Delaware determined Dec. 11 that the Boston Scientific U.S....
First TriCinch Coil Tricuspid Repair Systems Implanted in U.S.
News | Heart Valve Technology | November 06, 2018
4Tech Inc. initiated its U.S. Early Feasibility Study of the TriCinich Coil System following U.S. Food and Drug...
Valve Replacement Volume Key to Successful Patient Outcomes
News | Heart Valve Technology | November 02, 2018
Hospitals that routinely perform a heart valve replacement procedure requiring open heart surgery are more likely to...
Prosthetic Valve Mismatches Common in TAVR Procedures
News | Heart Valve Technology | October 03, 2018
A high number of patients in a study who underwent transcatheter aortic valve replacement (TAVR) experienced severe and...
Local Anesthesia Safe and Effective for Intermediate- and High-Risk TAVR Patients
News | Heart Valve Technology | September 28, 2018
The first randomized study to compare general versus local anesthesia during transcatheter aortic valve replacement (...
MitraClip Reduces Mortality for Heart Failure Patients With Secondary Mitral Regurgitation
News | Heart Valve Technology | September 26, 2018
Patients with heart failure and secondary mitral regurgitation (MR) who remained symptomatic despite maximally...
Ancora Heart Announces Positive Interim Analysis of AccuCinch Ventricular Repair System for Heart Failure
News | Heart Valve Technology | September 24, 2018
Ancora Heart Inc. announced positive clinical data from the company’s recently expanded U.S. early feasibility study...
Medtronic Announces TAVR Study of Aortic Stenosis Patients With Bicuspid Valves
News | Heart Valve Technology | September 19, 2018
The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) to initiate a new...
4C Medical's AltaValve First-in-Human Experience to be Presented at TCT 2018
News | Heart Valve Technology | September 17, 2018
September 17, 2018 — 4C Medical Technologies Inc.
Overlay Init